Lipocine
LPCN | NASDAQ
$1.66
-$0.05 (-2.92%)
At close: Nov 16, 2026, 4:00 PM ET
$1.66
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.92%
(1D)No price chart data available for 1D timeframe.
Rating
37.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #606/1021 (Top 59%)
Key Statistics
Market Data
Market Cap $18.38M
1D Range
1.64 1.71
52W Range
1.44 11.26
Valuation (TTM)
PE -1.22
PB 0.87
EV/EBITDA 0.36
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $4.00
Cash Flow
FCF Yield -15.9%
SBC Adj. FCF Yield -17.3%
SBC Impact -8.6%
Margins
Gross Margin 99.2%
Operating Margin -245.9%
FCF Margin -78.0%
Growth (CAGR)
Revenue 3Y | 5Y -39.2% |
132.6%
Dil EPS 3Y | 5Y -29.1% |
-18.2%
FCF 3Y | 5Y 24.2% |
6.0%
Returns
ROA -40.2%
ROE -46.5%
ROIC -47.6%
Financial Health
Net Cash
$21.46M
Current Ratio 11.36
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic condi...
Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Oct 22, 2013
Website www.lipocine.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.08
Beat +79.49%
YoY:
+86.44% REV
$2.29M
Beat +1335.78%
YoY:
+1898.77%Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Hold
Price Target
$4.00
Upside
+140.96%
Buy (0)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove LPCN